DCA Vantage HbA1c (DX Claim) Recall
Areazine synthesizes this Health Canada recall directly from Health Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
Siemens Healthcare Diagnostics Inc. recalls certain DCA Vantage® HbA1c (DX Claim) cartridges due to potential delamination of the buffer pull-tab.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on August 6, 2026 and geographically references Canada. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Product & Food Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, health-canada, MedicalDevice.
What Happened
Siemens Healthineers confirmed through customer complaint investigation and internal testing that delamination of the buffer pull-tab may occur in a small subset of cartridges. Delamination prevents full release of the buffer solution, reducing reagent volume and potentially causing falsely low HbA1c results or instrument error codes. The issue affects approximately 0.07-0.5% of cartridges in the affected lots.
Which Products Are Affected
- Product: DCA Vantage® HbA1c (DX Claim)
- Lot or serial number: 0916065
- Model or catalogue number: 10698915
- Company: Siemens Healthcare Diagnostics Inc., 511 Benedict Ave, Tarrytown, New York, United States, 10591
What You Should Do
No specific consumer actions are provided in the recall notice.
Why This Matters
Falsely low HbA1c results could affect diabetes monitoring and treatment decisions.
Source
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (980 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 6, 2026.
Frequently Asked Questions
Common questions about this Health Canada recall.